Novovax provisional approval for over 12s

By Melissa Meehan
Updated July 26 2022 - 2:51am, first published 2:48am
Australian adolescents could soon have access to the COVID-19 vaccine Nuvaxovid. (AP PHOTO)

Australian adolescents could soon have access to COVID-19 vaccine Nuvaxovid after the national medical regulator provisionally approved its use for children aged between 12 and 17 years old.

Advertisement

Ad

Get the latest Newcastle news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.